查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球過敏治療市場研究報告 - 2023 年至 2030 年行業分析、規模、佔有率、成長、趨勢和預測
市場調查報告書
商品編碼
1377827

全球過敏治療市場研究報告 - 2023 年至 2030 年行業分析、規模、佔有率、成長、趨勢和預測

Global Allergy Therapeutics Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030
出版日期: | 出版商: Value Market Research | 英文 190 Pages | 商品交期: 最快1-2個工作天內

價格

全球過敏治療市場需求預計將從 2022 年的 229 億美元增加到 2030 年的近 405.4 億美元，2023-2030 年研究期間CAGR為 7.4%。

過敏治療，也稱為過敏免疫療法或過敏注射，是一種旨在幫助過敏個體建立對特定過敏原（引發過敏反應的物質）的耐受性的醫學治療方法。過敏是免疫系統對花粉、塵蟎、寵物皮屑或某些食物等通常無害物質的反應。這可能會導致打噴嚏、搔癢、充血、蕁麻疹，在某些情況下甚至會導致嚴重的過敏反應。

市場動態：

全球過敏症盛行率不斷上升，包括過敏性鼻炎、氣喘和食物過敏等，對市場成長有正面影響。生活方式的改變、城市化和接觸環境過敏原促成了這一趨勢，促使個人尋求有效的過敏管理解決方案。治療方式的進步，包括舌下免疫療法 (SLIT) 片劑等創新選擇，為患者提供了比傳統過敏注射更方便、更個性化的替代方案。此外，患者對過敏的認知和教育的提高，加上醫療基礎設施的改善和專業護理的獲得，導致對過敏治療的需求更大。過敏測試技術的進步、政府促進有效過敏管理的舉措以及對職業過敏的認知進一步提振了市場。食物過敏、全球旅行以及對昆蟲毒液過敏治療的需求的增加也促進了市場的成長。製藥公司和學術機構之間正在進行的研究、臨床試驗以及合作正在推動新的和改進的過敏療法的開發。隨著過敏繼續影響公共健康和福祉，市場預計將擴大，為個人提供更有效和個人化的過敏管理選擇。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球過敏治療市場的每個細分市場進行了包容性評估。過敏治療產業的成長和趨勢為這項研究提供了整體方法。

區域分析：

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲過敏治療市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。過敏治療市場的主要參與者包括 Allergopharma、丹納赫、艾伯維公司、過敏治療公司、賽諾菲公司、輝瑞公司、梯瓦製藥工業有限公司、葛蘭素史克公司、羅氏公司和默克公司., Inc. 本部分包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概覽、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

目錄

第 1 章：前言

  • 報告說明
    • 客觀的
    • 目標受眾
    • 獨特的銷售主張 (USP) 和產品
  • 研究範圍
  • 研究方法論
    • 市場研究過程
    • 市場研究方法論

第 2 章：執行摘要

  • 市場亮點
  • 全球市場概況

第 3 章：過敏治療 - 產業分析

  • 簡介 - 市場動態
  • 市場促進因素
  • 市場限制
  • 機會
  • 產業動態
  • 波特五力分析
  • 市場吸引力分析
    • 按治療類型進行的市場吸引力分析
    • 按類型分類的市場吸引力分析
    • 按給藥途徑進行的市場吸引力分析
    • 按配銷通路分類的市場吸引力分析
    • 市場吸引力分析：按地區

第 4 章：價值鏈分析

  • 價值鏈分析
  • 原料分析
    • 原料清單
    • 原料廠商清單
    • 主要原物料價格走勢
  • 潛在買家名單
  • 行銷管道
    • 直效行銷
    • 間接行銷
    • 行銷通路發展趨勢

第 5 章：全球過敏治療市場分析：依治療類型

  • 按治療類型概述
  • 歷史和預測數據
  • 依治療類型分析
  • 抗過敏藥物（抗組織胺、皮質類固醇、其他藥物）
  • 免疫治療（皮下免疫治療（SCIT）、舌下免疫治療（SLIT））

第 6 章：全球過敏治療市場分析：按類型

  • 按類型概述
  • 歷史和預測數據
  • 按類型分析
  • 眼睛過敏
  • 氣喘
  • 皮膚過敏
  • 食物過敏
  • 鼻炎
  • 其他過敏類型

第 7 章：全球過敏治療市場分析：按給藥途徑

  • 依給藥途徑概述
  • 歷史和預測數據
  • 依給藥途徑分析
  • 口服
  • 吸入器
  • 鼻內
  • 其他給藥途徑

第 8 章：全球過敏治療市場分析：按分銷管道

  • 按配銷通路分類的概覽
  • 歷史和預測數據
  • 按配銷通路分析
  • 醫院藥房
  • 零售藥局
  • 其他分銷管道

第 9 章：全球過敏治療市場分析：按地理位置

  • 區域展望
  • 介紹
  • 北美銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 北美按細分市場銷售分析
    • 北美按國家銷售分析
    • 美國銷售分析
    • 加拿大銷售分析
    • 墨西哥銷售分析
  • 歐洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 歐洲按細分市場銷售分析
    • 歐洲按國家銷售分析
    • 英國銷售分析
    • 法國銷售分析
    • 德國銷售分析
    • 義大利銷售分析
    • 俄羅斯銷售分析
    • 歐洲其他地區銷售分析
  • 亞太地區銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 亞太地區按細分市場銷售分析
    • 亞太地區國家/地區銷售分析
    • 中國銷售分析
    • 印度銷售分析
    • 日本銷售分析
    • 韓國銷售分析
    • 澳洲銷售分析
    • 東南亞銷售分析
    • 亞太地區其他地區銷售分析
  • 拉丁美洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 拉丁美洲按細分市場銷售分析
    • 拉丁美洲按國家銷售分析
    • 巴西銷售分析
    • 阿根廷銷售分析
    • 秘魯銷售分析
    • 智利銷售分析
    • 拉丁美洲其他地區銷售分析
  • 中東和非洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 中東和非洲按細分市場銷售分析
    • 中東和非洲國家銷售分析
    • 沙烏地阿拉伯銷售分析
    • 阿拉伯聯合大公國銷售分析
    • 以色列銷售分析
    • 南非銷售分析
    • 中東其他地區和非洲銷售分析

第 10 章：過敏治療公司的競爭格局

  • 過敏治療市場競爭
  • 夥伴關係/協作/協議
  • 併購
  • 新產品發布
  • 其他發展

第 11 章：公司簡介

  • 公司股份分析
  • 市場集中度
  • Allergopharma
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Danaher
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • AbbVie Inc.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Allergy Therapeutics plc
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Sanofi SA
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Pfizer Inc.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Teva Pharmaceutical Industries Ltd.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • GlaxoSmithKline plc
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • F. Hoffmann-La Roche Ltd.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Merck & Co. Inc.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展

注意 - 在公司概況中，財務詳細資訊和近期發展視情況而定，或者如果是私人公司，則可能不包括在內

Product Code: VMR112112190

The global demand for Allergy Therapeutics Market is presumed to reach the market size of nearly USD 40.54 BN by 2030 from USD 22.9 BN in 2022 with a CAGR of 7.4% under the study period 2023 - 2030.

Allergy therapeutics, also known as allergy immunotherapy or allergy shots, are medical treatments designed to help individuals with allergies build a tolerance to specific allergens (substances that trigger allergic reactions). Allergy is an immune system response to normally harmless substances like pollen, dust mites, pet dander, or certain foods. This can lead to sneezing, itching, congestion, hives, or even severe allergic reactions in some cases.

MARKET DYNAMICS:

The increasing prevalence of allergies worldwide, including conditions like allergic rhinitis, asthma, and food allergies, is positively affecting the market growth. Lifestyle changes, urbanization, and exposure to environmental allergens contribute to this trend, prompting individuals to seek effective allergy management solutions. Advancements in treatment modalities, including innovative options like sublingual immunotherapy (SLIT) tablets, offer patients more convenient and personalized alternatives to traditional allergy shots. Additionally, heightened patient awareness and education about allergies, coupled with improved healthcare infrastructure and access to specialized care, have led to greater demand for allergy therapeutics. Technological advancements in allergy testing, government initiatives promoting effective allergy management, and the recognition of occupational allergies further bolster the market. The rise in food allergies, global travel, and the need for insect venom allergy treatments also contribute to market growth. Ongoing research, clinical trials, and collaborations between pharmaceutical companies and academic institutions are driving the development of new and improved allergy therapeutics. As allergies continue to impact public health and well-being, the market is expected to expand, providing individuals with more effective and personalized options for allergy management.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of allergy therapeutics. The growth and trends of allergy therapeutics industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the allergy therapeutics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Treatment Type

  • Anti-Allergy Drugs (Antihistamines, Corticosteroids., Other Drugs)
  • Immunotherapy (Sub-Cutaneous Immunotherapy (SCIT), Sub-Lingual Immunotherapy (SLIT))

By Type

  • Eye Allergy
  • Asthma
  • Skin Allergy
  • Food Allergies
  • Rhinitis
  • Other Allergy Types

By Route Of Administration

  • Oral
  • Inhalers
  • Intranasal
  • Other Routes Of Administration

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Other Distribution Channels

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Allergy Therapeutics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Allergy Therapeutics market include Allergopharma, Danaher, AbbVie Inc., Allergy Therapeutics plc, Sanofi SA, Pfizer Inc., Teva Pharmaceutical Industries Ltd., GlaxoSmithKline plc, F. Hoffmann-La Roche Ltd., and Merck & Co., Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . ALLERGY THERAPEUTICS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Treatment Type
    • 3.7.2 Market Attractiveness Analysis By Type
    • 3.7.3 Market Attractiveness Analysis By Route Of Administration
    • 3.7.4 Market Attractiveness Analysis By Distribution Channel
    • 3.7.5 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL ALLERGY THERAPEUTICS MARKET ANALYSIS BY TREATMENT TYPE

  • 5.1 Overview by Treatment Type
  • 5.2 Historical and Forecast Data
  • 5.3 Analysis by Treatment Type
  • 5.4 Anti-Allergy Drugs (Antihistamines, Corticosteroids., Other Drugs) Historic and Forecast Sales by Regions
  • 5.5 Immunotherapy (Sub-Cutaneous Immunotherapy (SCIT), Sub-Lingual Immunotherapy (SLIT)) Historic and Forecast Sales by Regions

6 . GLOBAL ALLERGY THERAPEUTICS MARKET ANALYSIS BY TYPE

  • 6.1 Overview by Type
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Type
  • 6.4 Eye Allergy Historic and Forecast Sales by Regions
  • 6.5 Asthma Historic and Forecast Sales by Regions
  • 6.6 Skin Allergy Historic and Forecast Sales by Regions
  • 6.7 Food Allergies Historic and Forecast Sales by Regions
  • 6.8 Rhinitis Historic and Forecast Sales by Regions
  • 6.9 Other Allergy Types Historic and Forecast Sales by Regions

7 . GLOBAL ALLERGY THERAPEUTICS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

  • 7.1 Overview by Route Of Administration
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Route Of Administration
  • 7.4 Oral Historic and Forecast Sales by Regions
  • 7.5 Inhalers Historic and Forecast Sales by Regions
  • 7.6 Intranasal Historic and Forecast Sales by Regions
  • 7.7 Other Routes Of Administration Historic and Forecast Sales by Regions

8 . GLOBAL ALLERGY THERAPEUTICS MARKET ANALYSIS BY DISTRIBUTION CHANNEL

  • 8.1 Overview by Distribution Channel
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by Distribution Channel
  • 8.4 Hospital Pharmacies Historic and Forecast Sales by Regions
  • 8.5 Retail Pharmacies Historic and Forecast Sales by Regions
  • 8.6 Other Distribution Channels Historic and Forecast Sales by Regions

9 . GLOBAL ALLERGY THERAPEUTICS MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America Sales Analysis
    • 9.3.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.3.2. North America By Segment Sales Analysis
    • 9.3.3. North America By Country Sales Analysis
    • 9.3.4. United State Sales Analysis
    • 9.3.5. Canada Sales Analysis
    • 9.3.6. Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.4.2. Europe by Segment Sales Analysis
    • 9.4.3. Europe by Country Sales Analysis
    • 9.4.4. United Kingdom Sales Analysis
    • 9.4.5. France Sales Analysis
    • 9.4.6. Germany Sales Analysis
    • 9.4.7. Italy Sales Analysis
    • 9.4.8. Russia Sales Analysis
    • 9.4.9. Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.5.2. Asia Pacific by Segment Sales Analysis
    • 9.5.3. Asia Pacific by Country Sales Analysis
    • 9.5.4. China Sales Analysis
    • 9.5.5. India Sales Analysis
    • 9.5.6. Japan Sales Analysis
    • 9.5.7. South Korea Sales Analysis
    • 9.5.8. Australia Sales Analysis
    • 9.5.9. South East Asia Sales Analysis
    • 9.5.10. Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.6.2. Latin America by Segment Sales Analysis
    • 9.6.3. Latin America by Country Sales Analysis
    • 9.6.4. Brazil Sales Analysis
    • 9.6.5. Argentina Sales Analysis
    • 9.6.6. Peru Sales Analysis
    • 9.6.7. Chile Sales Analysis
    • 9.6.8. Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.7.2. Middle East & Africa by Segment Sales Analysis
    • 9.7.3. Middle East & Africa by Country Sales Analysis
    • 9.7.4. Saudi Arabia Sales Analysis
    • 9.7.5. UAE Sales Analysis
    • 9.7.6. Israel Sales Analysis
    • 9.7.7. South Africa Sales Analysis
    • 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE ALLERGY THERAPEUTICS COMPANIES

  • 10.1. Allergy Therapeutics Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11 . COMPANY PROFILES OF ALLERGY THERAPEUTICS INDUSTRY

  • 11.1. Company Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Allergopharma
    • 11.3.1. Company Overview
    • 11.3.2. Company Revenue
    • 11.3.3. Products
    • 11.3.4. Recent Developments
  • 11.4. Danaher
    • 11.4.1. Company Overview
    • 11.4.2. Company Revenue
    • 11.4.3. Products
    • 11.4.4. Recent Developments
  • 11.5. AbbVie Inc.
    • 11.5.1. Company Overview
    • 11.5.2. Company Revenue
    • 11.5.3. Products
    • 11.5.4. Recent Developments
  • 11.6. Allergy Therapeutics plc
    • 11.6.1. Company Overview
    • 11.6.2. Company Revenue
    • 11.6.3. Products
    • 11.6.4. Recent Developments
  • 11.7. Sanofi SA
    • 11.7.1. Company Overview
    • 11.7.2. Company Revenue
    • 11.7.3. Products
    • 11.7.4. Recent Developments
  • 11.8. Pfizer Inc.
    • 11.8.1. Company Overview
    • 11.8.2. Company Revenue
    • 11.8.3. Products
    • 11.8.4. Recent Developments
  • 11.9. Teva Pharmaceutical Industries Ltd.
    • 11.9.1. Company Overview
    • 11.9.2. Company Revenue
    • 11.9.3. Products
    • 11.9.4. Recent Developments
  • 11.10. GlaxoSmithKline plc
    • 11.10.1. Company Overview
    • 11.10.2. Company Revenue
    • 11.10.3. Products
    • 11.10.4. Recent Developments
  • 11.11. F. Hoffmann-La Roche Ltd.
    • 11.11.1. Company Overview
    • 11.11.2. Company Revenue
    • 11.11.3. Products
    • 11.11.4. Recent Developments
  • 11.12. Merck & Co. Inc.
    • 11.12.1. Company Overview
    • 11.12.2. Company Revenue
    • 11.12.3. Products
    • 11.12.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Treatment Type (USD MN)
  • Anti-Allergy Drugs (Antihistamines, Corticosteroids., Other Drugs) Market Sales by Geography (USD MN)
  • Immunotherapy (Sub-Cutaneous Immunotherapy (SCIT), Sub-Lingual Immunotherapy (SLIT)) Market Sales by Geography (USD MN)
  • Analysis Market by Type (USD MN)
  • Eye Allergy Market Sales by Geography (USD MN)
  • Asthma Market Sales by Geography (USD MN)
  • Skin Allergy Market Sales by Geography (USD MN)
  • Food Allergies Market Sales by Geography (USD MN)
  • Rhinitis Market Sales by Geography (USD MN)
  • Other Allergy Types Market Sales by Geography (USD MN)
  • Analysis by Route Of Administration (USD MN)
  • Oral Market Sales by Geography (USD MN)
  • Inhalers Market Sales by Geography (USD MN)
  • Intranasal Market Sales by Geography (USD MN)
  • Other Routes Of Administration Market Sales by Geography (USD MN)
  • Analysis by Distribution Channel (USD MN)
  • Hospital Pharmacies Market Sales by Geography (USD MN)
  • Retail Pharmacies Market Sales by Geography (USD MN)
  • Other Distribution Channels Market Sales by Geography (USD MN)
  • Global Allergy Therapeutics Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Allergy Therapeutics Report
  • Market Research Process
  • Market Research Methodology
  • Global Allergy Therapeutics Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Treatment Type
  • Market Attractiveness Analysis by Type
  • Market Attractiveness Analysis by Route Of Administration
  • Market Attractiveness Analysis by Distribution Channel
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Treatment Type (USD MN)
  • Anti-Allergy Drugs (Antihistamines, Corticosteroids., Other Drugs) Market Sales by Geography (USD MN)
  • Immunotherapy (Sub-Cutaneous Immunotherapy (SCIT), Sub-Lingual Immunotherapy (SLIT)) Market Sales by Geography (USD MN)
  • Global Market Analysis by Type (USD MN)
  • Eye Allergy Market Sales by Geography (USD MN)
  • Asthma Market Sales by Geography (USD MN)
  • Skin Allergy Market Sales by Geography (USD MN)
  • Food Allergies Market Sales by Geography (USD MN)
  • Rhinitis Market Sales by Geography (USD MN)
  • Other Allergy Types Market Sales by Geography (USD MN)
  • Global Market Analysis by Route Of Administration (USD MN)
  • Oral Market Sales by Geography (USD MN)
  • Inhalers Market Sales by Geography (USD MN)
  • Intranasal Market Sales by Geography (USD MN)
  • Other Routes Of Administration Market Sales by Geography (USD MN)
  • Global Market Analysis by Distribution Channel (USD MN)
  • Hospital Pharmacies Market Sales by Geography (USD MN)
  • Retail Pharmacies Market Sales by Geography (USD MN)
  • Other Distribution Channels Market Sales by Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.